In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard.

The reliability of absolute quantification of average metabolite concentrations in the human brain in vivo by 1H-MRS using the fully relaxed water signal as an internal standard was tested in a number of in vitro as well as in vivo measurements. The experiments were carried out on a SIEMENS HELICON SP 63/84 wholebody MR-scanner operating at 1.5 T using a STEAM sequence. In vitro studies indicate a very high correlation between metabolite signals (area under peaks) and concentration, R = 0.99 as well as between metabolite signals and the volume of the selected voxel, R = 1.00. The error in quantification of N-acetyl aspartate (NAA) concentration was about 1-2 mM (6-12%). Also in vivo a good linearity between water signal and selected voxel size was seen. The same was true for the studied metabolites, N-acetyl aspartate (NAA), creatine/phosphocreatine (Cr/PCr), and choline (Cho). Calculated average concentrations of NAA, Cr/PCr, and Cho in the occipital lobe of the brain in five healthy volunteers were (mean +/- 1 SD) 11.6 +/- 1.3 mM, 7.6 +/- 1.4 mM, and 1.7 +/- 0.5 mM. The results indicate that the method presented offers reasonable estimation of metabolite concentrations in the brain in vivo and therefore is useful in clinical research.

[1]  P R Luyten,et al.  Experimental approaches to image localized human 31P NMR spectroscopy , 1989, Magnetic resonance in medicine.

[2]  C. Hardy,et al.  A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic? , 1987, Medical physics.

[3]  H. Bruhn,et al.  Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.

[4]  J. Olesen,et al.  Assessment of demyelination, edema, and gliosis by in vivo determination of T1 and T2 in the brain of patients with acute attack of multiple sclerosis , 1989, Magnetic resonance in medicine.

[5]  T. Bohan,et al.  Regional in vivo proton magnetic resonance spectroscopy of brain , 1989 .

[6]  P. Tofts,et al.  A critical assessment of methods of measuring metabolite concentrations by NMR spectroscopy , 1988, NMR in biomedicine.

[7]  P A Narayana,et al.  In vivo proton magnetic resonance spectroscopy studies of human brain. , 1991, Magnetic resonance imaging.

[8]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[9]  R S Balaban,et al.  Quantitative 1H magnetization transfer imaging in vivo , 1991, Magnetic resonance in medicine.

[10]  J. Olesen,et al.  Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis , 1991, Magnetic resonance in medicine.

[11]  P. Tofts,et al.  Direct in vivo measurement of absolute metabolite concentrations using 31P nuclear magnetic resonance spectroscopy. , 1986, Biochimica et biophysica acta.

[12]  Y Van Haverbeke,et al.  The uncommon longitudinal relaxation dispersion of human brain white matter , 1989, Magnetic resonance in medicine.

[13]  P A Rinck,et al.  Nuclear relaxation of human brain gray and white matter: Analysis of field dependence and implications for MRI , 1990, Magnetic resonance in medicine.

[14]  K Suzuki,et al.  SUBACUTE SCLEROSING LEUKOENCEPHALITIS: II. CHEMICAL STUDIES INCLUDING ABNORMAL MYELIN AND AN ABNORMAL GANGLIOSIDE PATTERN , 1966, Journal of neuropathology and experimental neurology.

[15]  Keith R Thulborn,et al.  Absolute molar concentrations by NMR in inhomogeneous B1. A scheme for analysis of in vivo metabolites , 1983 .

[16]  R G Shulman,et al.  Spatially localized 1H NMR spectra of metabolites in the human brain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.